<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Phil</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Oldroyd, Keith G.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Preventive PCI in Nonculprit Vessels Adds Benefit to PCI of Culprit Vessels in Patients with Acute STEMI</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">14-14</style></pages><abstract><style  face="normal" font="default" size="100%">Percutaneous coronary intervention (PCI) improves outcomes in patients with acute ST elevation myocardial infarction (STEMI). This article presents the results of the Preventive Angioplasty in Acute Myocardial Infarction trial [PRAMI; Wald DS et al. N Engl J Med 2013], which was designed to determine whether performing preventive PCI in nonculprit vessels at the same time as primary PCI would reduce the combined incidence of death from cardiac causes, nonfatal myocardial infarction, or refractory angina.</style></abstract><number><style face="normal" font="default" size="100%">13</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>